A Study of the Mechanisms for Antiaggregant Activity of Pyrrolidone Derivatives in Rats with Chronic Hyperglycemia

Abstract

In rats with chronic alloxan-induced hyperglycemia, pramiracetam and phenylpiracetam (but not piracetam) had a strong antiaggregant effect that was mediated by various mechanisms of platelet aggregation modulation. The effect of pramiracetam is mainly realized via the inhibition of thromboxane A2 metabolism, while activity of phenylpiracetam is primarily associated with a normalizing effect on function of constitutive NO synthase in platelets and vascular endothelium.

DOI: 10.1007/s10517-014-2454-8

Extracted Key Phrases

5 Figures and Tables

Cite this paper

@article{Zhilyuk2014ASO, title={A Study of the Mechanisms for Antiaggregant Activity of Pyrrolidone Derivatives in Rats with Chronic Hyperglycemia}, author={V. I. Zhilyuk and A. E. Levykh and Vitaliy Mamchur}, journal={Bulletin of Experimental Biology and Medicine}, year={2014}, volume={156}, pages={799-802} }